List of Top 10 Human Rabies Antibody Brands Popular in European and American Countries

April 18, 2024

The human rabies antibody consumer market is driven by the increasing awareness about the importance of vaccination for Rabies Prevention. The market is also growing due to the rising cases of rabies infections worldwide. Pharmaceutical companies are investing in research and development to develop more effective and affordable human rabies antibody products to cater to the growing demand. The market is expected to witness significant growth in the coming years as governments and healthcare organizations continue to prioritize rabies prevention and control efforts.

HRIG
Changchun Zhuoyi Biological Co., Ltd
KEDRAB
Imogam Rabies-HT

HRIG

Establishment time : 1987

website : www.hrig.com

Main Product : Human Resources consulting services

Company Profile

HRIG is a leading provider of human resources consulting services, specializing in talent acquisition, employee development, and organizational effectiveness. With over 30 years of experience, we have helped numerous companies improve their HR practices and achieve their business goals. Our team of experienced consultants is dedicated to providing innovative solutions tailored to meet each client's unique needs.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

KEDRAB

Establishment time : KEDRAB is a biopharmaceutical company specializing in rabies immune globulin products.

website :

Main Product : KEDRAB's main product is a rabies immune globulin that is used in post-exposure prophylaxis for rabies.

Company Profile

Overall, KEDRAB is dedicated to providing effective and innovative solutions for rabies prevention and treatment.

Imogam Rabies-HT

Establishment time : Imogam Rabies-HT is a leading provider of rabies immunoglobulin.

website :

Main Product : Imogam Rabies-HT's products are used worldwide to prevent the spread of rabies.

Company Profile

Imogam Rabies-HT continues to innovate and improve its products to combat rabies.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326